Novo Nordisk announced on Thursday that a key European Medicines Agency committee has backed a label update for weight-loss ...

But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...

Cleveland Clinic researchers have found definitive proof of a kidney microbiome that influences renal health and kidney stone ...

Many biotechnology companies don't have approved products on the market, so they don't generate reliable revenue. From time ...

After Luigi Mangione made the difficult decision to undergo spinal surgery last year for chronic back pain, he became a ...

If left untreated, PsA can worsen, so, don’t delay. Early, aggressive treatment improves your chance of controlling PsA. Disease-modifying drugs called DMARDs are used to treat PsA. Your treatment ...